Home LiteratureArticle Details
PMID: 13587851 Published · ppublish English Journal Article

Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma.

The Journal of experimental medicine ·Vol. 108 ·No. 5 ·1958-11-01 ·Pages 685-99

SKARNES RC, ROSEN FS, SHEAR MJ, LANDY M

Abstract

A humoral substance which inactivates endotoxin in vitro has been shown to be clearly distinguishable from complement, properdin, and specific antibody. For the present, it is designated "endotoxin-detoxifying component" or EDC. Animal species could be grouped in three categories with regard to the EDC activity of their sera; rat serum was highly potent; chimpanzee, dog, horse, and guinea pig sera were much less active; mouse, rabbit, and sheep sera exhibited no activity. The EDC potency of human sera varied widely, ranging from high to barely discernible activity. In contrast to the variations of EDC potency in serum, citrated plasma from all species manifested high potency of about the same magnitude. The influence of time, temperature, pH, and concentration of reactants on the inactivation of endotoxin by EDC was examined. EDC activity in plasma and serum was found to be labile to beating at 56 degrees C. for 1 hour. Bacterial endotoxins, derived by different isolation procedures from smooth and rough Gram-negative species, varied considerably in susceptibility to EDC action.

Keywords
BACTERIA BLOOD
MeSH Terms
Animals Bacteria Blood Complement System Proteins Dogs Endotoxins Guinea Pigs Horses Humans Mice Plasma Rabbits Rats Sheep
Chemicals
Endotoxins Complement System Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
SKARNES R C
ROSEN F S
SHEAR M J
LANDY M
References (19)
19 references, click to expand
  1. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.
    J Exp Med. 1956 Sep 1;104(3):383-409 PMID: 13357692
  2. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.
    Science. 1954 Aug 20;120(3112):279-85 PMID: 13186838
  3. Inactivation of a bacterial pyrogen by human serum and plasma.
    Clin Sci. 1956 Nov;15(4):491-5 PMID: 13374934
  4. Protective effect of components of normal blood against the lethal action of endotoxin.
    J Lab Clin Med. 1958 Feb;51(2):297-311 PMID: 13514238
  5. Bacterial pyrogens.
    Pharmacol Rev. 1957 Dec;9(4):427-79 PMID: 13517946
  6. The effect of bacterial constituents on the resistance of mice to heterologous infection and on the activity of their reticulo-endothelial system.
    J Exp Med. 1958 Apr 1;107(4):523-36 PMID: 13513916
  7. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.
    J Immunol. 1954 Sep;73(3):146-58 PMID: 13201755
  8. A study of the effect of serum on the immunological reaction of a bacterial endotoxin.
    J Exp Med. 1956 Apr 1;103(4):439-52 PMID: 13306853
  9. Inactivation of biologically active endotoxic polysaccharides by fresh human serum.
    Proc Soc Exp Biol Med. 1957 Dec;96(3):744-7 PMID: 13505847
  10. Similarity of host responses elicited by polysaccharides of animal and plant origin and by bacterial endotoxins.
    J Exp Med. 1957 Jul 1;106(1):77-97 PMID: 13439117
  11. Preparation and properties of antihuman properdin rabbit serum.
    Science. 1957 Jun 21;125(3260):1244-5 PMID: 13432791
  12. [Study of the toxin R2 of the typhoid bacilli (Eberthella typhosa)].
    Ann Inst Pasteur (Paris). 1952 Feb;82(2):206-220 PMID: 14952936
  13. [Studies on the nature of the pyrogen-neutralizing factor in normal human blood. II. Temperature susceptibility of the neutralizing factor and of its effectiveness].
    Z Immun exp ther. 1956 Jun;113(3):201-7 PMID: 13353352
  14. Studies on the O antigen of Salmonella typhosa. I. Purification of the antigen.
    J Immunol. 1955 Jun;74(6):455-65 PMID: 14392331
  15. A reaction between fresh serum and lipopolysaccharides of gram-negative bacteria.
    Br J Exp Pathol. 1958 Feb;39(1):90-8 PMID: 13510553
  16. The inactivation of complement and its components by plasmin.
    J Exp Med. 1953 Apr;97(4):573-89 PMID: 13052820
  17. [Determination of the antigen O in bacteria of strain O 901].
    Ann Inst Pasteur (Paris). 1951 Jan;80(1):21-39 PMID: 14829876
  18. The requirement for a hydrazine-sensitive serum factor and heat-labile serum factors in the inactivation of human C'3 by zymosan.
    J Immunol. 1953 Nov;71(5):339-45 PMID: 13118170
  19. Inactivation of endotoxin by a humoral component. III. Role of divalent cation and a dialyzable component.
    J Exp Med. 1958 Nov 1;108(5):701-11 PMID: 13587852
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1958-11-01
Pages
685-99
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2136910
Subset
OM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]